Skip to main content
Top
Published in: Endocrine 2/2020

01-02-2020 | Acromegaly | Original Article

Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly

Authors: Yanghua Fan, Yansheng Li, Yichao Li, Shanshan Feng, Xinjie Bao, Ming Feng, Renzhi Wang

Published in: Endocrine | Issue 2/2020

Login to get access

Abstract

Purpose

Preoperative prediction of transsphenoidal surgical (TSS) response is important for determining individual treatment strategies for acromegaly. There is currently no accurate predictive model for TSS response for acromegaly. The current study sought to develop and validate machine learning (ML)-based models for preoperative prediction of TSS response for acromegaly.

Methods

Six hundred sixty-eight patients with acromegaly were enrolled and divided into training (n = 534) and text datasets (n = 134) in this retrospective, data mining and ML study. The forward search algorithm was used to select features, and six ML algorithms were applied to construct TSS response prediction models. The performance of these ML models was validated using receiver operating characteristics analysis. Model calibration, discrimination ability, and clinical usefulness were also assessed.

Results

Three hundred forty-nine (52.2%) patients achieved postoperative remission criteria and exhibited good TSS response. A univariate analysis was conducted and eight features, including age, hypertension, ophthalmic disorders, GH, IGF-1, nadir GH, maximal tumor diameter, and Knosp grade, were significantly associated with the TSS response in patients with acromegaly. After feature selection, the gradient boosting decision tree (GBDT), which was constructed with the eight significant features showed the best favorable discriminatory ability both the training (AUC = 0.8555) and validation (AUC = 0.8178) cohorts. The GBDT model showed good discrimination ability and calibration, with the highest levels of accuracy and specificity, and provided better estimates of TTS responses of patients with acromegaly compared with using only the Knosp grade. Decision curve analysis confirmed that the model was clinically useful.

Conclusions

ML-based models could aid neurosurgeons in the preoperative prediction of TTS response for patients with acromegaly, and could contribute to determining individual treatment strategies.
Appendix
Available only for authorised users
Literature
1.
go back to reference S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanueva, J.A.H. Wass et al. A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14(9), 552–61 (2018)PubMed S. Melmed, M.D. Bronstein, P. Chanson, A. Klibanski, F.F. Casanueva, J.A.H. Wass et al. A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14(9), 552–61 (2018)PubMed
2.
go back to reference D. Esposito, O. Ragnarsson, D. Granfeldt, T. Marlow, G. Johannsson, D.S. Olsson, Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. Eur. J. Endocrinol. 178(5), 459–69. (2018)PubMed D. Esposito, O. Ragnarsson, D. Granfeldt, T. Marlow, G. Johannsson, D.S. Olsson, Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. Eur. J. Endocrinol. 178(5), 459–69. (2018)PubMed
3.
go back to reference C. Leopoldo, F. Leopoldo, A. Santos, J.C.E. Veiga, J.V.J. Lima, N.M. Scalissi et al. Long term follow-up of growth hormone-secreting pituitary adenomas submitted to endoscopic endonasal surgery. Arq. Neuropsiquiatr. 75(5), 301–6 (2017)PubMed C. Leopoldo, F. Leopoldo, A. Santos, J.C.E. Veiga, J.V.J. Lima, N.M. Scalissi et al. Long term follow-up of growth hormone-secreting pituitary adenomas submitted to endoscopic endonasal surgery. Arq. Neuropsiquiatr. 75(5), 301–6 (2017)PubMed
4.
go back to reference A. Buliman, L.G. Tataranu, V. Ciubotaru, T.L. Cazac, C. Dumitrache, The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes. J. Med. Life 9(2), 187–92 (2016)PubMedPubMedCentral A. Buliman, L.G. Tataranu, V. Ciubotaru, T.L. Cazac, C. Dumitrache, The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes. J. Med. Life 9(2), 187–92 (2016)PubMedPubMedCentral
5.
go back to reference S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94(5), 1509–17 (2009)PubMed S. Melmed, A. Colao, A. Barkan, M. Molitch, A.B. Grossman, D. Kleinberg et al. Guidelines for acromegaly management: an update. J. Clin. Endocrinol. Metab. 94(5), 1509–17 (2009)PubMed
6.
go back to reference L. Katznelson, E.R. Laws Jr., S. Melmed, M.E. Molitch, M.H. Murad, A. Utz et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–51 (2014)PubMed L. Katznelson, E.R. Laws Jr., S. Melmed, M.E. Molitch, M.H. Murad, A. Utz et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933–51 (2014)PubMed
7.
go back to reference B. Zhao, Y.K. Wei, G.L. Li, Y.N. Li, Y. Yao, J. Kang et al. Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J. Neurosurg. 112(1), 108–17 (2010)PubMed B. Zhao, Y.K. Wei, G.L. Li, Y.N. Li, Y. Yao, J. Kang et al. Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J. Neurosurg. 112(1), 108–17 (2010)PubMed
8.
go back to reference M.E. Sughrue, E.F. Chang, R.A. Gabriel, M.K. Aghi, L.S. Blevins, Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary 14(3), 276–83 (2011)PubMed M.E. Sughrue, E.F. Chang, R.A. Gabriel, M.K. Aghi, L.S. Blevins, Excess mortality for patients with residual disease following resection of pituitary adenomas. Pituitary 14(3), 276–83 (2011)PubMed
9.
go back to reference S.M. Carlsen, M. Lund-Johansen, T. Schreiner, S. Aanderud, O. Johannesen, J. Svartberg et al. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 93(8), 2984–90 (2008)PubMed S.M. Carlsen, M. Lund-Johansen, T. Schreiner, S. Aanderud, O. Johannesen, J. Svartberg et al. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J. Clin. Endocrinol. Metab. 93(8), 2984–90 (2008)PubMed
10.
go back to reference V.S. Nunes, J.M. Correa, M.E. Puga, E.M. Silva, C.L. Boguszewski, Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system. Pituitary 18(4), 500–8 (2015)PubMed V.S. Nunes, J.M. Correa, M.E. Puga, E.M. Silva, C.L. Boguszewski, Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system. Pituitary 18(4), 500–8 (2015)PubMed
11.
go back to reference S. Bacigaluppi, F. Gatto, P. Anania, N.L. Bragazzi, D.C. Rossi, G. Benvegnu et al. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center. Endocrine 51(3), 524–33. (2016)PubMed S. Bacigaluppi, F. Gatto, P. Anania, N.L. Bragazzi, D.C. Rossi, G. Benvegnu et al. Impact of pre-treatment with somatostatin analogs on surgical management of acromegalic patients referred to a single center. Endocrine 51(3), 524–33. (2016)PubMed
12.
go back to reference S. Yano, N. Shinojima, J. Kawashima, T. Kondo, T. Hide, Intraoperative scoring system to predict postoperative remission in endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. World Neurosurg. 105, 375–85. (2017)PubMed S. Yano, N. Shinojima, J. Kawashima, T. Kondo, T. Hide, Intraoperative scoring system to predict postoperative remission in endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas. World Neurosurg. 105, 375–85. (2017)PubMed
13.
go back to reference W.J. Zhou, S.C. Ma, M. Zhao, C. Liu, X.D. Guan, Z.S. Bao et al. Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis. Asian J. Androl. 20(1), 43–9 (2018)PubMed W.J. Zhou, S.C. Ma, M. Zhao, C. Liu, X.D. Guan, Z.S. Bao et al. Risk factors and the prognosis of sexual dysfunction in male patients with pituitary adenomas: a multivariate analysis. Asian J. Androl. 20(1), 43–9 (2018)PubMed
14.
go back to reference M. Birkhahn, A.P. Mitra, R.J. Cote, Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev. Anticancer Ther. 7(12), 1717–27. (2007)PubMed M. Birkhahn, A.P. Mitra, R.J. Cote, Molecular markers for bladder cancer: the road to a multimarker approach. Expert Rev. Anticancer Ther. 7(12), 1717–27. (2007)PubMed
15.
go back to reference Y. Huang, Z. Liu, L. He, X. Chen, D. Pan, Z. Ma et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281(3), 947–57. (2016)PubMed Y. Huang, Z. Liu, L. He, X. Chen, D. Pan, Z. Ma et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung cancer. Radiology 281(3), 947–57. (2016)PubMed
16.
go back to reference T.J. Cleophas, Machine learning in therapeutic research: the hard work of outlier detection in large data. Am. J. Ther. 23(3), e837–43 (2016)PubMed T.J. Cleophas, Machine learning in therapeutic research: the hard work of outlier detection in large data. Am. J. Ther. 23(3), e837–43 (2016)PubMed
17.
go back to reference M.H. Al-Mallah, R. Elshawi, A.M. Ahmed, W.T. Qureshi, C.A. Brawner, M.J. Blaha et al. Using Machine Learning to Define the Association between Cardiorespiratory Fitness and All-Cause Mortality (from the Henry Ford Exercise Testing Project). Am. J. Cardiol. 120(11), 2078–84. (2017)PubMed M.H. Al-Mallah, R. Elshawi, A.M. Ahmed, W.T. Qureshi, C.A. Brawner, M.J. Blaha et al. Using Machine Learning to Define the Association between Cardiorespiratory Fitness and All-Cause Mortality (from the Henry Ford Exercise Testing Project). Am. J. Cardiol. 120(11), 2078–84. (2017)PubMed
18.
go back to reference A. Rajkomar, J. Dean, I. Kohane, Machine Learning in Medicine. N. Engl. J. Med 380(14), 1347–58. (2019)PubMed A. Rajkomar, J. Dean, I. Kohane, Machine Learning in Medicine. N. Engl. J. Med 380(14), 1347–58. (2019)PubMed
20.
go back to reference A.M. Bur, A. Holcomb, S. Goodwin, J. Woodroof, O. Karadaghy, Y. Shnayder et al. Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma. Oral. Oncol. 92, 20–5 (2019)PubMed A.M. Bur, A. Holcomb, S. Goodwin, J. Woodroof, O. Karadaghy, Y. Shnayder et al. Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma. Oral. Oncol. 92, 20–5 (2019)PubMed
21.
go back to reference C. Rubbert, C. Mathys, C. Jockwitz, C.J. Hartmann, S.B. Eickhoff, F. Hoffstaedter et al. Machine-learning identifies parkinson’s disease patients based on resting-state between-network functional connectivity. Br. J. Radio. 92, 20180886 (2019) C. Rubbert, C. Mathys, C. Jockwitz, C.J. Hartmann, S.B. Eickhoff, F. Hoffstaedter et al. Machine-learning identifies parkinson’s disease patients based on resting-state between-network functional connectivity. Br. J. Radio. 92, 20180886 (2019)
22.
go back to reference H. Yu, H. Wu, W. Wang, S. Jolly, J.Y. Jin, C. Hu, et al., Machine learning to build and validate a model for radiation pneumonitis prediction in patients with non-small-cell lung cancer. Clin. Cancer Res 25, 4343–4350 (2019).PubMed H. Yu, H. Wu, W. Wang, S. Jolly, J.Y. Jin, C. Hu, et al., Machine learning to build and validate a model for radiation pneumonitis prediction in patients with non-small-cell lung cancer. Clin. Cancer Res 25, 4343–4350 (2019).PubMed
23.
go back to reference X. Guo, L. Gao, Y. Zhao, M. Wang, B. Jiang, Q. Wang et al. Characteristics of the upper respiratory tract in patients with acromegaly and correlations with obstructive sleep apnoea/hypopnea syndrome. Sleep. Med. 48, 27–34 (2018)PubMed X. Guo, L. Gao, Y. Zhao, M. Wang, B. Jiang, Q. Wang et al. Characteristics of the upper respiratory tract in patients with acromegaly and correlations with obstructive sleep apnoea/hypopnea syndrome. Sleep. Med. 48, 27–34 (2018)PubMed
24.
go back to reference E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4), 610–7 (1993). discussion 7–8PubMed E. Knosp, E. Steiner, K. Kitz, C. Matula, Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4), 610–7 (1993). discussion 7–8PubMed
25.
go back to reference A. Di Ieva, F. Rotondo, L.V. Syro, M.D. Cusimano, K. Kovacs, Aggressive pituitary adenomas–diagnosis and emerging treatments. Nat. Rev. Endocrinol. 10(7), 423–35 (2014)PubMed A. Di Ieva, F. Rotondo, L.V. Syro, M.D. Cusimano, K. Kovacs, Aggressive pituitary adenomas–diagnosis and emerging treatments. Nat. Rev. Endocrinol. 10(7), 423–35 (2014)PubMed
26.
go back to reference G.E.A.P.A. Batista, M.C. Monard, An analysis of four missing data treatment methods for supervised learning. Appl. Artif. Intell. 17(5–6), 519–33 (2003) G.E.A.P.A. Batista, M.C. Monard, An analysis of four missing data treatment methods for supervised learning. Appl. Artif. Intell. 17(5–6), 519–33 (2003)
27.
go back to reference L.A. Shalabi, Z. Shaaban, B. Kasasbeh, Data mining: a preprocessing engine. J. Computer Sci. 2(9), 735–9 (2006) L.A. Shalabi, Z. Shaaban, B. Kasasbeh, Data mining: a preprocessing engine. J. Computer Sci. 2(9), 735–9 (2006)
28.
go back to reference Y. Liu, X. Liu, X. Hong, P. Liu, X. Bao, Y. Yao et al. Prediction of recurrence after transsphenoidal surgery for cushing’s disease: the use of machine learning algorithms. Neuroendocrinology 108(3), 201–10. (2019)PubMed Y. Liu, X. Liu, X. Hong, P. Liu, X. Bao, Y. Yao et al. Prediction of recurrence after transsphenoidal surgery for cushing’s disease: the use of machine learning algorithms. Neuroendocrinology 108(3), 201–10. (2019)PubMed
29.
go back to reference Y.V. Sun, Multigenic modeling of complex disease by random forests. Adv. Genet 72, 73–99 (2010)PubMed Y.V. Sun, Multigenic modeling of complex disease by random forests. Adv. Genet 72, 73–99 (2010)PubMed
30.
go back to reference B. Fu, P. Liu, J. Lin, L. Deng, K. Hu, H. Zheng. Predicting invasive disease-free survival for early-stage breast cancer patients using follow-up clinical data. IEEE Trans. Biomed. Eng. 66(7), 2053–64 (2019) B. Fu, P. Liu, J. Lin, L. Deng, K. Hu, H. Zheng. Predicting invasive disease-free survival for early-stage breast cancer patients using follow-up clinical data. IEEE Trans. Biomed. Eng. 66(7), 2053–64 (2019)
31.
go back to reference Y. Jung, Multiple predicting K-fold cross-validation for model selection. J. Nonparametr. Stat. 30(1), 197–215 (2018) Y. Jung, Multiple predicting K-fold cross-validation for model selection. J. Nonparametr. Stat. 30(1), 197–215 (2018)
32.
go back to reference S.M. Erturk, Receiver operating characteristic analysis. AJR Am. J. Roentgenol. 197(4), W784 (2011).PubMed S.M. Erturk, Receiver operating characteristic analysis. AJR Am. J. Roentgenol. 197(4), W784 (2011).PubMed
33.
go back to reference A.A. Kramer, J.E. Zimmerman, Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited. Crit. Care Med 35(9), 2052–6 (2007)PubMed A.A. Kramer, J.E. Zimmerman, Assessing the calibration of mortality benchmarks in critical care: The Hosmer-Lemeshow test revisited. Crit. Care Med 35(9), 2052–6 (2007)PubMed
34.
go back to reference A.J. Vickers, A.M. Cronin, E.B. Elkin, M. Gonen, Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inf. Decis. Mak. 8, 53 (2008) A.J. Vickers, A.M. Cronin, E.B. Elkin, M. Gonen, Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inf. Decis. Mak. 8, 53 (2008)
35.
go back to reference E.H. Kim, M.C. Oh, J.H. Chang, J.H. Moon, C.R. Ku, W.S. Chang et al. Postoperative gamma knife radiosurgery for cavernous sinus-invading growth hormone-secreting pituitary adenomas. World Neurosurg. 110, e534–e45. (2018)PubMed E.H. Kim, M.C. Oh, J.H. Chang, J.H. Moon, C.R. Ku, W.S. Chang et al. Postoperative gamma knife radiosurgery for cavernous sinus-invading growth hormone-secreting pituitary adenomas. World Neurosurg. 110, e534–e45. (2018)PubMed
36.
go back to reference J.J. Jacob, J.S. Bevan, Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long? Clin. Endocrinol. 81(6), 812–7 (2014) J.J. Jacob, J.S. Bevan, Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long? Clin. Endocrinol. 81(6), 812–7 (2014)
37.
go back to reference L. Duan, H. Zhu, B. Xing, F. Gu, Prolonged preoperative treatment of acromegaly with somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center. BMC Endocr. Disord. 17(1), 55 (2017)PubMedPubMedCentral L. Duan, H. Zhu, B. Xing, F. Gu, Prolonged preoperative treatment of acromegaly with somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center. BMC Endocr. Disord. 17(1), 55 (2017)PubMedPubMedCentral
38.
go back to reference C.B. Newman, S. Melmed, A. George, D. Torigian, M. Duhaney, P. Snyder et al. Octreotide as primary therapy for acromegaly. J. Clin. Endocrinol. Metab. 83(9), 3034–40. (1998)PubMed C.B. Newman, S. Melmed, A. George, D. Torigian, M. Duhaney, P. Snyder et al. Octreotide as primary therapy for acromegaly. J. Clin. Endocrinol. Metab. 83(9), 3034–40. (1998)PubMed
39.
go back to reference M. Fleseriu, A.R. Hoffman, L. Katznelson, A. Neuroendocrine; Pituitary Scientific C, American association of clinical endocrinologists and american college of endocrinology disease state clinical review: management of acromegaly patients: what is the role of pre-operative medical therapy? Endocr. Pract. 21(6), 668–73 (2015)PubMed M. Fleseriu, A.R. Hoffman, L. Katznelson, A. Neuroendocrine; Pituitary Scientific C, American association of clinical endocrinologists and american college of endocrinology disease state clinical review: management of acromegaly patients: what is the role of pre-operative medical therapy? Endocr. Pract. 21(6), 668–73 (2015)PubMed
40.
go back to reference N. Qiao. A systematic review on machine learning in sellar region diseases: quality and reporting items. Endocr. Connect. 8(7), 952–60 (2019)PubMedPubMedCentral N. Qiao. A systematic review on machine learning in sellar region diseases: quality and reporting items. Endocr. Connect. 8(7), 952–60 (2019)PubMedPubMedCentral
41.
go back to reference V.E. Staartjes, C.M. Zattra, K. Akeret, N. Maldaner, G. Muscas, C.H. Bas van Niftrik et al. Neural network-based identification of patients at high risk for intraoperative cerebrospinal fluid leaks in endoscopic pituitary surgery. J. Neurosurg. 21, 1–7 (2019) V.E. Staartjes, C.M. Zattra, K. Akeret, N. Maldaner, G. Muscas, C.H. Bas van Niftrik et al. Neural network-based identification of patients at high risk for intraoperative cerebrospinal fluid leaks in endoscopic pituitary surgery. J. Neurosurg. 21, 1–7 (2019)
42.
go back to reference V.E. Staartjes, C. Serra, G. Muscas, N. Maldaner, K. Akeret, C.H.B. van Niftrik et al. Utility of deep neural networks in predicting gross-total resection after transsphenoidal surgery for pituitary adenoma: a pilot study. Neurosurg. Focus 45(5), E12 (2018)PubMed V.E. Staartjes, C. Serra, G. Muscas, N. Maldaner, K. Akeret, C.H.B. van Niftrik et al. Utility of deep neural networks in predicting gross-total resection after transsphenoidal surgery for pituitary adenoma: a pilot study. Neurosurg. Focus 45(5), E12 (2018)PubMed
43.
go back to reference T.C. Hollon, A. Parikh, B. Pandian, J. Tarpeh, D.A. Orringer, A.L. Barkan et al. A machine learning approach to predict early outcomes after pituitary adenoma surgery. Neurosurg. Focus 45(5), E8 (2018)PubMed T.C. Hollon, A. Parikh, B. Pandian, J. Tarpeh, D.A. Orringer, A.L. Barkan et al. A machine learning approach to predict early outcomes after pituitary adenoma surgery. Neurosurg. Focus 45(5), E8 (2018)PubMed
44.
go back to reference H. Babu, A. Ortega, M. Nuno, A. Dehghan, A. Schweitzer, H.V. Bonert et al. Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 81(2), 357–66. (2017)PubMed H. Babu, A. Ortega, M. Nuno, A. Dehghan, A. Schweitzer, H.V. Bonert et al. Long-term endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors. Neurosurgery 81(2), 357–66. (2017)PubMed
45.
go back to reference M.T. Ribeiro, S. Singh, C. Guestrin. “Why Should I Trust You?”: Explaining the Predictions of Any Classifier. (2016) M.T. Ribeiro, S. Singh, C. Guestrin. “Why Should I Trust You?”: Explaining the Predictions of Any Classifier. (2016)
46.
go back to reference Rudin C. Please Stop Explaining Black Box Models for High Stakes Decisions. (2018) Rudin C. Please Stop Explaining Black Box Models for High Stakes Decisions. (2018)
47.
go back to reference I. Shimon, Z.R. Cohen, Z. Ram, M. Hadani, Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48(6), 1239–43 (2001)PubMed I. Shimon, Z.R. Cohen, Z. Ram, M. Hadani, Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48(6), 1239–43 (2001)PubMed
48.
go back to reference I. Anik, B. Cabuk, A. Gokbel, A. Selek, B. Cetinarslan, Y. Anik et al. Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria. World Neurosurg. 108, 278–90. (2017)PubMed I. Anik, B. Cabuk, A. Gokbel, A. Selek, B. Cetinarslan, Y. Anik et al. Endoscopic transsphenoidal approach for acromegaly with remission rates in 401 patients: 2010 consensus criteria. World Neurosurg. 108, 278–90. (2017)PubMed
49.
go back to reference X. Antunes, N. Ventura, G.B. Camilo, L.E. Wildemberg, A. Guasti, P.J.M. Pereira et al. Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60(3), 415–22. (2018)PubMed X. Antunes, N. Ventura, G.B. Camilo, L.E. Wildemberg, A. Guasti, P.J.M. Pereira et al. Predictors of surgical outcome and early criteria of remission in acromegaly. Endocrine 60(3), 415–22. (2018)PubMed
Metadata
Title
Development and assessment of machine learning algorithms for predicting remission after transsphenoidal surgery among patients with acromegaly
Authors
Yanghua Fan
Yansheng Li
Yichao Li
Shanshan Feng
Xinjie Bao
Ming Feng
Renzhi Wang
Publication date
01-02-2020
Publisher
Springer US
Keyword
Acromegaly
Published in
Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02121-6

Other articles of this Issue 2/2020

Endocrine 2/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.